Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When may research be stopped?

C Cohen

    The New England Journal of Medicine
    |May 26, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Arguments for prohibiting recombinant DNA research are flawed. No valid scientific principle or evidence demonstrates that this research is intolerably hazardous, thus it should not be stopped.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does the density of lymphatic vascular space invasion affect the prognosis of stage Ib and IIA node negative carcinoma of the cervix?

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
    Same author

    SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

    The Journal of pharmacology and experimental therapeutics·2003
    Same author

    Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study.

    Toxicology in vitro : an international journal published in association with BIBRA·2002
    Same author

    SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

    Behavioural pharmacology·2002
    Same author

    Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.

    Applied immunohistochemistry & molecular morphology : AIMM·2002
    Same author

    Crystallographic findings on the internally uncoupled and near-rigor states of myosin: further insights into the mechanics of the motor.

    Proceedings of the National Academy of Sciences of the United States of America·2002
    Same journal

    Ebola at 50 - Lessons for Outbreak Response and Preparedness.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients. Reply.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    See all related articles

    Area of Science:

    • Molecular Biology
    • Bioethics

    Background:

    • Concerns regarding the safety and ethical implications of recombinant DNA technology have been raised.
    • Proposals for prohibiting recombinant DNA research necessitate a clear principle identifying intolerable hazards.

    Purpose of the Study:

    • To evaluate the logical and evidential basis for prohibiting recombinant DNA research.
    • To determine if existing arguments against recombinant DNA research are sound.

    Main Methods:

    • Analysis of the logical structure of arguments for prohibition.
    • Examination of the premises supporting claims of intolerable defects or hazards in recombinant DNA research.

    Main Results:

    • No successful argument establishes a universal principle for prohibiting research based on intolerable hazards.

    Related Experiment Videos

  • Arguments for prohibition either rely on false principles or lack established evidence regarding recombinant DNA research's specific risks.

    • Conclusions:

    • The prohibition of recombinant DNA research is not supported by valid reasoning or sufficient evidence.
    • Current arguments fail to demonstrate that recombinant DNA research poses intolerable risks warranting a ban.